Form 8-K - Current report:
SEC Accession No. 0001213900-15-001553
Filing Date
2015-03-04
Accepted
2015-03-04 16:20:17
Documents
4
Period of Report
2015-02-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k022615_actiniumpharma.htm 8-K 28680
2 CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORPORATION f8k022615ex3i_actinium.htm EX-3.1 17468
3 GRAPHIC img1.jpg GRAPHIC 18925
4 GRAPHIC img2.jpg GRAPHIC 4737
  Complete submission text file 0001213900-15-001553.txt   80246
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 15673628
SIC: 2834 Pharmaceutical Preparations